Double Bond Pharmaceutical International AB Logo

Double Bond Pharmaceutical International AB

DBP B | SPGR

Overview

Corporate Details

ISIN(s):
SE0007185517 (+1 more)
LEI:
254900U1MWE2YSPREX74
Country:
Sweden
Address:
Virdings Alle 32B, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Double Bond Pharmaceutical International AB is a pharmaceutical company specializing in the redevelopment of established drugs to improve their safety and efficacy. The company's strategy centers on applying its proprietary drug delivery technologies to create new formulations of proven medications. Its key platforms include BeloGal®, a biomimetic encapsulation system that enables targeted delivery of active ingredients to specific organs, and an innovative hydrogel for localized treatment. This approach aims to enhance therapeutic effects while minimizing systemic toxicity. The company's pipeline focuses on areas with significant unmet medical needs, such as oncology and infectious diseases. Lead candidates include SI-053 for glioblastoma (brain cancer), SA-033 for liver cancer, and Belopenem for pneumonia.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Double Bond Pharmaceutical International AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Double Bond Pharmaceutical International AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Double Bond Pharmaceutical International AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo Japan 4582
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Radiopharmaceuticals, medical devices & IT solutions for oncology, cardiology, and neurology.
Poland SNT
Synthaverse S.A. Logo
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland BML
TAIKO PHARMACEUTICAL CO., LTD. Logo Japan 4574
Takeda Pharmaceutical Company Limited Logo Japan 4502
TAUNS Laboratories, Inc. Logo Japan 197A
Tchaikapharma High Quality Medicines AD Logo
Manufactures affordable generic & complex polypill medicines for socially significant diseases.
Bulgaria THQM
Teva Pharmaceutical Industries Ltd. Logo
A global leader in generic drugs and innovative medicines for CNS and immuno-oncology.
Israel TEVA